This site is intended only for healthcare professionals resident in the Republic of Ireland
Lung cancer continous to be a leading cause of cancer mortality worldwide,1 impacting millions of people around the world. For patients diagnosed between 2012 and 2018 with NSCLC with distant metastases (SEER Stage), the 5-year survival rate was only 9%,2 highlighting the importance of early diagnosis, optimized treatment options and successful management of adverse events to improve patients' quality of life. Find out more about the recent advances in this field and what you can do to improve outcomes for your patients.
Adverse events should be reported. Report an adverse event to your national reporting system (HPRA Pharmacovigilance)
Adverse events should also be reported to Pfizer Medical Information on 1800 633 363
Please sign in or register to gain access to information relating to Pfizer medicines and vaccines, medical conditions, patient materials and services.
This site is intended only for healthcare professionals resident in the Republic of Ireland. If you are a member of the public wishing to access information on a specific medicine, please visit https://www.medicines.ie
This website is brought to you by Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24, Ireland. Registered in the Republic of Ireland No. 127002.
Copyright © 2023 Pfizer Limited. All rights reserved.
The information contained on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland.
I confirm that I am a healthcare professional resident in the Republic of Ireland.*
If you select 'No', you will be redirected to Pfizer.ie, where you will be able to access information on Pfizer Healthcare Ireland.
PP-UNP-IRL-0176. January 2023